Trade Summary

2 days ago, Ceesay Abraham, serving as Chief Executive Officer at Rapport Therapeutics, Inc. (RAPP), sold 8,210 shares at $40.00 per share, for a total transaction value of $328,436.72. Following this transaction, Ceesay Abraham now holds 539,817 shares of RAPP.

This sale represents a 1.50% decrease in Ceesay Abraham's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, July 14, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, July 15, 2026 at 4:15 PM ET, 1 day after the trade was made.

Rapport Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.